Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-7.32%
-0.94%
-1.99%
-0.53%
+0.14%
ZTS
Zoetis
$146.67
Login to see Zoetis (ZTS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Earnings are forecast to grow
Upgraded on attractively valued
Pays a reliable dividend
Risk Analysis
Trading above its fair value
Chart
$151.75 (-3.35%)
$154.96 (-5.35%)
$160.41 (-8.57%)
$191 (-23.21%)
ZTS has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
ZTS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Revenue increase YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Pays a reliable dividend
Future
Future
Earnings are forecast to grow
Trading above its fair value
ZTS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ZTS Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayZTS Earnings
The TTM reflects 12-month period, providing review of ZTS financial performance.
The company financial health has moderately improved over the past year
Financial Score
MRK
89.32
-0.62%
SNY
50.39
+0.46%
OGN
11.08
+1.23%
NVS
132.27
+0.99%
NVO
58.72
-0.03%
What is ZTS current stock price?
What are ZTS stock strengths?
What risks are associated with ZTS stock?
When is ZTS next earnings report?
What is ZTS market cap and volume?
What is ZTS's current Stock IQ?
Should I buy ZTS stock right now?
Is ZTS a Strong Buy right now?
What does a 'Strong Buy' rating mean for ZTS?
What does a 'Strong Sell' rating mean for ZTS?
What factors influence ZTS's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-7.32%
-0.94%
-1.99%
-0.53%
+0.14%
ZTS
Zoetis
Current Price
$146.67
Stock Insights
Strengths
Earnings are forecast to grow
Upgraded on attractively valued
Pays a reliable dividend
Risk Analysis
Trading above its fair value
Linked to ZTS
MRK
89.32
-0.62%
SNY
50.39
+0.46%
OGN
11.08
+1.23%
NVS
132.27
+0.99%
NVO
58.72
-0.03%
Login to unlock Zoetis (ZTS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$151.75 (-3.35%)
$154.96 (-5.35%)
$160.41 (-8.57%)
$191 (-23.21%)
ZTS Analysts Opinion
ZTS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Revenue increase YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Pays a reliable dividend
Future
Future
Earnings are forecast to grow
Trading above its fair value
ZTS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ZTS Street view is extremely bullish and have positive views on the near-term outlook
ZTS has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
Login to displayZTS Earnings
The TTM data reflects the most recent 12-month period, providing overview of ZTS financial performance.
ZTS Financial Health
The company financial health has moderately improved over the past year
Financial Score
ZTS Latest Analysis
Zoetis: A Solid Investment in the Growing Pet Medicine Market?. Explore the exciting world of Zoetis (NYSE: ZTS) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!.Stock prices used were the prices of Sep.
Thu Oct 2, 2025
Zoetis: Much Bark Little Bite - The Stock Remains Pricey.
Thu Oct 2, 2025
IDEXX Laboratories Inc. (IDXX) Stock Delivers 97% Return in 3 Years Outpacing Zoetis and Market. We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. IDEXX Laboratories Inc. is one of them. IDEXX Laboratories Inc. (NASDAQ:IDXX) specializes in animal health diagnostics veterinary software and laboratory services supporting companion animals livestock water testing and food safety worldwide. Its platforms including imaging systems in-clinic [….]
Wed Oct 1, 2025
Zoetis granted conditional approval of Dectomax-CA1 for parasitic infection in cattle.
Tue Sep 30, 2025
Zoetis stock rises after FDA conditionally approves screwworm drug.
Tue Sep 30, 2025
Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing. Zoetis (ZTS) concluded the recent trading session at $143.5 signifying a 1.68% move from its prior days close.
Fri Sep 26, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings